Seizure-related visits increased to almost prepandemic levels for all age groups by end of 2020, except among those aged 0 to 9 years
Cancer Patients Confronted with Lessening Effective COVID-19 Vaccines
A new study published in the peer-review The Lancet Oncology has found that while COVID-19 vaccination is effective in most cancer patients, protection against infection, hospitalization, and death is less than in the general population.
And COVID-19 vaccine effectiveness wanes more quickly in certain cancer patients.
Cholera Elimination Campaign Launches in Malawi
The WHO Africa announced today that the country of Malawi successfully launched a cholera vaccination campaign targeting more than 1.9 million children.
Local health authorities, with support from World Health Organization (WHO) and other partners, will carry out the two-round campaign in eight cholera hotspot districts of Nsanje, Chikwawa, Phalombe, Mulanje, Blantyre, Machinga, Mangochi, and Balaka.
The first round started on May 23, 2022, and will be followed by a second-round two to six weeks later.
Post-COVID Conditions Are Common Among Adult Survivors
More than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
Are There Enough Monkeypox Vaccines for Everyone?
The goal of any preventive vaccination program is to limit the spread of disease in the community. However, with monkeypox infections occurring in about twenty countries, anyone who has been in close contact with an infected person could qualify for vaccination.
"I want to emphasize that we're in the early days of this (monkeypox) response. Unfortunately, additional cases will likely be reported in the U.S.," Jennifer McQuiston, a deputy director of the CDC's National Center for Emerging and Zoonotic Diseases, reported RollCall on May 23, 2022.
COVID-19 Can ‘Rebound’ After Treatment With Paxlovid, CDC Says
In these cases, the illness improved or resolved within an average of three days
Burden of Persistent Symptoms High After COVID-19 Infection
No specific causes of symptoms of postacute sequelae of SARS-CoV-2 infection identified
After 23 Years, New Bladder Cancer Treatment Seeks FDA Approval
An innovative treatment combination, including a 100-year-old vaccine, may soon become available to certain bladder cancer patients in the USA.
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving hormone replacement therapy within six months of recorded COVID-19 diagnosis linked to reduction in mortality